Because it hits three targets, data shows that it may be even more effective for weight loss than semaglutide or tirzepatide, leading to almost a 28% reduction in body weight after 68 weeks
At the same time, GLP-1 reduces the release of another hormone called glucagon, which raises blood sugar
If reconstituted differently, recalculate using your actual concentration
Y., Alfulaij, N., Berry, M
In absolute terms, breast cancer risk in the matched analysis was 1.62% among GLP-1-exposed women and 2.31% among matched women without exposure, corresponding to an absolute risk reduction of 0.69% during the study period
metformin 1000 mg BID led to conflicting results on hyperandrogenism